Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00139971
Status:
UNKNOWN
Last Update Posted:
2006-01-06
First Post:
2005-08-30
Brief Title:
Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer
Sponsor:
West Japan Thoracic Oncology Group
Organization:
West Japan Thoracic Oncology Group
Organization Data
Organization:
West Japan Thoracic Oncology Group
Class:
OTHER
Study ID:
WJTOG0101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
West Japan Thoracic Oncology Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None